MENU
VMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

VMD stock forecast, quote, news & analysis

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
VMD
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for VMD with price predictions
Oct 21, 2026

VMD in upward trend: 10-day moving average moved above 50-day moving average on October 09, 2026

The 10-day moving average for VMD crossed bullishly above the 50-day moving average on October 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on VMD as a result. In 70 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

VMD moved above its 50-day moving average on October 06, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +3.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where VMD advanced for three days, in 230 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

The Aroon Indicator entered an Uptrend today. In 189 of 236 cases where VMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for VMD moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 22 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 58%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for VMD moved below the 200-day moving average on October 06, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

VMD broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. VMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.578) is normal, around the industry mean (2.923). P/E Ratio (26.351) is within average values for comparable stocks, (2.388). Projected Growth (PEG Ratio) (1.910) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.202) is also within normal values, averaging (40.124).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.76B. The market cap for tickers in the group ranges from 837 to 173.92B. ABT holds the highest valuation in this group at 173.92B. The lowest valued company is DHAI at 837.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was -2%. For the same Industry, the average monthly price growth was -11%, and the average quarterly price growth was -10%. CTSO experienced the highest price growth at 78%, while LUCD experienced the biggest fall at -39%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -17%. For the same stocks of the Industry, the average monthly volume growth was 25% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 48
Price Growth Rating: 62
SMR Rating: 89
Profit Risk Rating: 95
Seasonality Score: 14 (-100 ... +100)
View a ticker or compare two or three
VMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the provision of home healthcare solutions

Industry MedicalNursingServices

Industry
N/A
Address
625 E. Kaliste Saloom Road
Phone
+1 337 504-3802
Employees
1382
Web
https://www.viemed.com
VMD in upward trend: 10-day moving average moved above 50-day moving average on October 09, 2026